Volume 19, 2015 Archive

Six issues from 2015 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issue/Volume	Title
Issues Included
January/February 2015 Vol. 19 No. 1	Volume 19, Number 1
March/April 2015 Vol. 19 No. 2	Volume 19, Number 2
May/June 2015 Vol. 19 No. 3	Volume 19, Number 3
July/August 2015 Vol. 19 No. 4	Volume 19, Number 4
September/October 2015 Vol. 19 No. 5	Volume 19, Number 5
November/December 2015 Vol. 19 No. 6	Volume 19, Number 6

Volume 19, 2015 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2015 Pg. 4	PreScription: 2014 in Review Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 6-12	Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015 Pg. 14-17	Giving Back: A Win-Win Plan of Action for Compounding Pharmacists Author(s): Rudner Shara
Jan/Feb 2015 Pg. 18-27	Pharmacy Student Survey: Perceptions and Expectations of Pharmaceutical Compounding Author(s): Carvalho Maria, Batra Bindhu
Jan/Feb 2015 Pg. 30-37	Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance Author(s): Grilli Anthony, Sutton Scott
Jan/Feb 2015 Pg. 38-40	Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 43-47	Quality Control Analytical Methods: Refractive Index Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 49-56	Basics of Sterile Compounding: Aseptic Processing Author(s): Akers Michael J
Jan/Feb 2015 Pg. 57-58	Basics of Compounding: The Revised "Not to Compound List" Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 59	Calculations Author(s): Stockton Shelly J
Jan/Feb 2015 Pg. 60	Atenolol 25-, 50-, or 100-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 61	Azathioprine 50-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 62	Cisplatin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 63	Daunorubicin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 64	Erythromycin 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 65	Hydralazine Hydrochloride 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 66	Hydroxychloroquine Sulfate 200-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 67	Lidocaine Hydrochloride 4% Topical Solution Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 68	Mupirocin 2% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 69	Phentolamine Mesylate 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 70-72	Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration Author(s): Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J
Jan/Feb 2015 Pg. 73-77	Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Author(s): Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
Jan/Feb 2015 Pg. 78-85	Stability of Suspensions: Theoretical and Practical Considerations before Compounding Author(s): Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina
Jan/Feb 2015 Pg. 86-87	PostScription: Pharmacists Advancing Toward Provider Status Author(s): Menighan Thomas E
Mar/Apr 2015 Pg. 92	PreScription: Some of the Best Sermons are Lived, not Preached! Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 94-102	New England Compounding Center Indictment Author(s): Cabaleiro Joe
Mar/Apr 2015 Pg. 104-106	Standing Together Fixing the Drug Quality and Security Act Author(s): Miller David G
Mar/Apr 2015 Pg. 109-112	Standarized Compounding: The Importance of Doing it the Same Way Every Time Author(s): Dillon L Rad
Mar/Apr 2015 Pg. 115-118	Bedside Manner: Not Just for Doctors Anymore Author(s): Cormier Mindy
Mar/Apr 2015 Pg. 121-124	Quality Assurance and Quality Control, Part 1 Author(s): Akers Michael J
Mar/Apr 2015 Pg. 127-138	Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Author(s): Akers Michael J
Mar/Apr 2015 Pg. 140-141	Calculations Author(s): Stockton Shelly J
Mar/Apr 2015 Pg. 142	Acne Scrub Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 143	Aminohippurate Sodium 200-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 144	Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 145	Heparin 335-United/Gram Gel-Cream Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 146	L-Cysteine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 147	Morrhuate Sodium 5% Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 148	Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 149	Pancuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 150	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 151	Trypan Blue 0.06% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 152-160	Transdermal Delivery of Nisoldipine: Refinement of Vehicles Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2015 Pg. 161-166	Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Mar/Apr 2015 Pg. 167-173	Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Author(s): Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Mar/Apr 2015 Pg. 174-175	PostScription: What's Your Patient Care Story? Author(s): Menighan Thomas E
May/Jun 2015 Pg. 180	PreScription: 2015 Student Pharmacist Compounding Competition Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 182-192	Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities Author(s): Weller Tom, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan
May/Jun 2015 Pg. 195-203	Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Author(s): Guth Michael AS
May/Jun 2015 Pg. 205-211	Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls Author(s): Gonzalez Mark
May/Jun 2015 Pg. 212	IACP Says: "Fix DQSA" Author(s): Miller David
May/Jun 2015 Pg. 215-221	Quality Assurance and Quality Control, Part 2 Author(s): Akers Michael J
May/Jun 2015 Pg. 223-230	Basics of Compounding: Compounding with Silicones Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 232-238	Basics of Sterile Compounding: Contamination Control Author(s): Akers Michael J
May/Jun 2015 Pg. 240-241	Calculations Author(s): Stockton Shelly J, Saluja Hardeep Singh
May/Jun 2015 Pg. 242	Atropine Sulfate 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 243	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 244	Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 245	Phenazopyridine Hydrochloride 200-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 246	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 247	Scopolamine Hydrobromide -.4-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 248-251	Stability of Metronidazole Suspensions Author(s): Donnelly Ronald F, Ying James
May/Jun 2015 Pg. 252-260	Protocol of Blood Serum Eye Drops Author(s): Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
May/Jun 2015 Pg. 261-267	Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Author(s): Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
May/Jun 2015 Pg. 268-270	Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles Author(s): Dewulf Joseph, Hecq Jean-Daniel, Huvelle Sophie, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
May/Jun 2015 Pg. 271	PostScription: Opportunities to Change the Pharmacy Landscape Author(s): Menighan Thomas E
Jul/Aug 2015 Pg. 266	PreScription: Potpourri of Opinions…From Many Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 268-278	Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Author(s): Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jul/Aug 2015 Pg. 280-287	Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 289-293	Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Author(s): Biundo Bruce, Gogola Margaret
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Jul/Aug 2015 Pg. 307-310	Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units Author(s): Sidhu Raman
Jul/Aug 2015 Pg. 311-313	Basics of Compounding: The "Negative" List Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 315-320	Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing Author(s): Akers Michael J
Jul/Aug 2015 Pg. 322	Calculations Author(s): Stockton Shelly J
Jul/Aug 2015 Pg. 324	Ammonium Molybdate 25-mcg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 325	Balsam Peru, Castor Oil, and Trypsin Ointment Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 326	Benzonatate 100-mg Capsules Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 327	Chloroquine Phosphate 250-mg Capsules Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 328	Cytarabine 50-mg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 329	Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 330	Oxytocin 10-units/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 331	Phytonadione 2-mg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 332	Proparacaine Hydrochloride 0.5% Ophthalmic Solution Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 333	Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 334-336	Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Author(s): Puertos Enrique, Spencer Melissa
Jul/Aug 2015 Pg. 337-339	Stability of Prednisone in Oral Mix Suspending Vehicle Author(s): Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
Jul/Aug 2015 Pg. 340-343	Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals Author(s): Meek Claudia, Rothardt Andrew, Evans Jason, Thurman Rosanne, Ashworth Lisa, Leff Richard
Jul/Aug 2015 Pg. 344-347	Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Author(s): Anderson Collin R, Halford Zachery, MacKay Mark
Jul/Aug 2015 Pg. 348-349	PostScription: APhA2015: You Spoke, We Listened, and What a Success! Author(s): Menighan Thomas E
Sep/Oct 2015 Pg. 354	PreScription: Failure or Success? Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015 Pg. 367-373	Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Author(s): Guth Michael AS
Sep/Oct 2015 Pg. 375	The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Author(s): Miller David G
Sep/Oct 2015 Pg. 377-380	The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
Sep/Oct 2015 Pg. 383-386	Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Author(s): Donnelly Ronald F
Sep/Oct 2015 Pg. 389-390	Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 393-401	Sterile Filtration Author(s): Akers Michael J
Sep/Oct 2015 Pg. 402	Calculations Author(s): Stockton Shelly J, Saluja Hardeep Singh
Sep/Oct 2015 Pg. 404	Aminocaproic Acid 250-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 405	Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 406	Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 407	Nimodipine 3-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 408	Ofloxacin 0.3% Otic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 409	Povidone Iodine 10% Cold Sore Paint Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 410	Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 411	Vehicle for Oral Solution (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 412	Vehicle for Oral Solution, Sugar Free (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 413	Vehicle for Oral Suspension (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 414-419	Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Author(s): Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Sep/Oct 2015 Pg. 420-427	Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Sep/Oct 2015 Pg. 428-431	Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures Author(s): Nahata Milap C
Sep/Oct 2015 Pg. 432-436	In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Author(s): Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra
Sep/Oct 2015 Pg. 437	PostScription: Progress Report: Provider Status Continues to Gain Strength! Author(s): Menighan Thomas E
Nov/Dec 2015 Pg. 442	PreScription: The Documented Past and the Exciting Future Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 444-446	Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless Arithmetic Nullifies Careful Compounding" Author(s): Newton David W
Nov/Dec 2015 Pg. 449-450	International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Author(s): Miller David G
Nov/Dec 2015 Pg. 453-463	Applying Quality of Design Concepts to Pharmacy Compounding Author(s): Timko Robert J
Nov/Dec 2015 Pg. 465-469	Root Cause Analysis, Part 1: Nonsterile Compounding Author(s): Cabaleiro Joe, Jackson Kathleen
Nov/Dec 2015 Pg. 471-476	Basic Principles of Lyophilization, Part 1 Author(s): Akers Michael J
Nov/Dec 2015 Pg. 479-484	Mixing in a Compounding Pharmacy in the 21st Century Author(s): Standridge Rob
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 491-500	Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Author(s): Akers Michael J
Nov/Dec 2015 Pg. 502	Calculations Author(s): Stockton Shelly J
Nov/Dec 2015 Pg. 504	Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 505	Cefepime Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 506	Cefotaxime 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 507	Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 508	Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 509	Estradiol Valerate 40-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 510	Levetiracetam 100-mg/mL Injection (Concentrate) Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 511	Memantine Hydrochloride Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 512	Mupirocin 2% Nasal Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 513	Propranolol Hydrochloride Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 514-520	Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Author(s): Lobb William B, Wilkin Noel E, Holmes Erin R
Nov/Dec 2015 Pg. 521-524	Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment Author(s): Hecq Jean-Daniel, Rolin Catherine, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Nov/Dec 2015 Pg. 525	PostScription: Pharmacy Fellowship Program: Building a Stronger Profession Author(s): Bernardi Steve